Status: current, Defined. Date: 31-Mar 2021. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 4531511000168114 | mogamulizumab 20 mg / 5 mL injection, 5 mL vial (medicinal product unit of use) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 4531521000168119 | mogamulizumab 20 mg/5 mL injection, vial | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| mogamulizumab 20 mg/5 mL injection, vial | Is a | mogamulizumab | true | Inferred relationship | Some | ||
| mogamulizumab 20 mg/5 mL injection, vial | Is a | medicinal product unit of use | true | Inferred relationship | Some | ||
| mogamulizumab 20 mg/5 mL injection, vial | has manufactured dose form | injection | true | Inferred relationship | Some | ||
| mogamulizumab 20 mg/5 mL injection, vial | has Australian BoSS | mogamulizumab | true | Inferred relationship | Some | 1342659585 | |
| mogamulizumab 20 mg/5 mL injection, vial | has intended active ingredient | mogamulizumab | true | Inferred relationship | Some | 1342659585 | |
| mogamulizumab 20 mg/5 mL injection, vial | has unit of use | vial | true | Inferred relationship | Some | 1529160785 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Poteligeo 20 mg/5 mL injection, 5 mL vial | Is a | True | mogamulizumab 20 mg/5 mL injection, vial | Inferred relationship | Some | |
| mogamulizumab 20 mg/5 mL injection, 5 mL vial | has MPUU | True | mogamulizumab 20 mg/5 mL injection, vial | Inferred relationship | Some | 1237100822 |
Reference Sets
Medicinal product unit of use reference set
FHIR